Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.5725 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.66563 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.64054 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.35613 | 56 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.61905 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.74554 | 61 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.66723 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.01322 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.64677 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.66179 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.68122 | 62 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.64301 | 61 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.69225 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.65568 | 61 |